Volume 125, Issue 3, Pages (September 2003)

Slides:



Advertisements
Similar presentations
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Advertisements

Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice  Susana Sánchez-Fidalgo, Ana Cárdeno, Marina.
Christian F. Krieglstein, Christoph Anthoni, Wolfgang H
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 123, Issue 4, Pages (October 2002)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 143, Issue 5, Pages (November 2012)
Volume 132, Issue 4, Pages (April 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 136, Issue 3, Pages (March 2009)
Volume 138, Issue 3, Pages e4 (March 2010)
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 131, Issue 4, Pages (October 2006)
Volume 123, Issue 4, Pages (October 2002)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 128, Issue 4, Pages (April 2005)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 24, Issue 5, Pages (November 2013)
Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat  Koichiro Wada, Michael C. Montalto,
Volume 123, Issue 1, Pages (July 2002)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
Volume 136, Issue 2, Pages (February 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 20, Issue 5, Pages (November 2011)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice  Tohru Funakoshi, Kenichiro Yamashita, Nobuki.
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 1, Pages (July 2012)
Volume 117, Issue 4, Pages (October 1999)
Volume 115, Issue 2, Pages (August 1998)
Volume 130, Issue 6, Pages (May 2006)
Volume 133, Issue 3, Pages (September 2007)
Volume 125, Issue 6, Pages (December 2003)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 138, Issue 4, Pages (April 2010)
Volume 125, Issue 6, Pages (December 2003)
Volume 134, Issue 7, Pages e3 (June 2008)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
The Loss of MCP-1 Attenuates Cutaneous Ischemia–Reperfusion Injury in a Mouse Model of Pressure Ulcer  Yuki Saito, Minoru Hasegawa, Manabu Fujimoto, Takashi.
Volume 132, Issue 3, Pages (March 2007)
Volume 116, Issue 4, Pages (April 1999)
Volume 117, Issue 2, Pages (August 1999)
Volume 19, Issue 13, Pages (June 2017)
Volume 119, Issue 4, Pages (October 2000)
Volume 146, Issue 7, Pages e4 (June 2014)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 120, Issue 2, Pages (February 2001)
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 119, Issue 3, Pages (September 2000)
Volume 41, Issue 4, Pages (October 2014)
Volume 118, Issue 2, Pages (July 2004)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Volume 127, Issue 5, Pages (November 2004)
Volume 132, Issue 2, Pages (February 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 122, Issue 5, Pages (May 2002)
Volume 117, Issue 5, Pages (November 1999)
Volume 140, Issue 4, Pages (April 2011)
Volume 118, Issue 2, Pages (July 2004)
Volume 136, Issue 7, Pages (June 2009)
Presentation transcript:

Volume 125, Issue 3, Pages 775-785 (September 2003) Dietary glycine prevents chemical-induced experimental colitis in the rat  Isao Tsune, Kenichi Ikejima, Miyoko Hirose, Mutsuko Yoshikawa, Nobuyuki Enomoto, Yoshiyuki Takei, Nobuhiro Sato  Gastroenterology  Volume 125, Issue 3, Pages 775-785 (September 2003) DOI: 10.1016/S0016-5085(03)01067-9

Figure 1 Macroscopic changes of the colon after TNBS treatment. Rats fed a diet containing 5% glycine or casein as controls for 3 days were given a single intracolonic injection of TNBS (50 mg in 50% ethanol/rat) as described in detail in the Materials and Methods section. The gross appearance of (A) the colon and macroscopic changes of the (B) luminal side of the distal colon were observed 5 days after TNBS treatment. Bars indicate 5-cm and 1-cm lengths in A and B, respectively. The wet weight of distal 8-cm portions of the colon were measured (C, n = 10; ∗P < 0.05 vs. control-diet/saline group; #P < 0.05 vs. control-diet/TNBS group). The average levels of macroscopic score 5 days after TNBS treatment are plotted (D, ∗n = 10; P < 0.05 vs. control-diet/TNBS group). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 2 Histopathologic changes and tissue MPO activities in the colon after TNBS treatment. Experimental design as in Figure 1. Representative microphotographs of the colonic tissue from the (A) control-diet group without TNBS, and 5 days after TNBS treatment with (B, C) control diet and (D, E) glycine diet are shown (H&E staining original magnification: B, D, 40×; C, E, 400×). The average levels of histologic scoring at day 5 of TNBS treatment are plotted (F, n = 10; means ± SEM; ∗P < 0.05 vs. control-diet/TNBS). MPO activities in the colonic tissue 2 days after TNBS treatment were determined by a standard enzymatic procedure as described in the Materials and Methods section (G, n = 5; means ± SEM; ∗P ≤ 0.05 vs. control-diet/saline; #P ≤ 0.05 vs. control-diet/TNBS). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 3 Expression of IL-1β and TNF-α mRNA and protein levels in the colon after TNBS treatment. IL-1β and TNF-α mRNA levels in the colonic tissue 2 days after TNBS treatment were measured by RT-PCR. (A) Representative photographs of the specific bands for IL-1β, TNF-α, and β-actin are shown. Data of densitometric analysis for (B) IL-1β and (C) TNF-α are plotted (n = 5; ∗P < 0.05 vs. control-diet/saline; #P < 0.05 vs. control-diet/TNBS). IL-1β and TNF-α protein levels in the colonic tissue 2 days after TNBS treatment were measured by ELISA. Mean values for (D) IL-1β and (E) TNF-α are plotted (n = 5; ∗P < 0.05 vs. control-diet/saline; #P < 0.05 vs. control-diet/TNBS). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 4 Expression of CINC and MIP-2 mRNA and protein levels in the colon after TNBS treatment. Experimental design as in Figure 4 except that CINC and MIP-2 mRNA levels were measured by RT-PCR. (A) Representative photographs of the specific bands for CINC, MIP-2, and β-actin are shown. Data of densitometric analysis for (B) CINC and (C) MIP-2 are plotted (n = 5; ∗P < 0.05 vs. control-diet/saline; #P < 0.05 vs. control-diet/TNBS). CINC and MIP-2 protein levels in the colonic tissue 2 days after TNBS treatment were measured by ELISA. Mean values for (D) CINC and (E) MIP-2 are plotted (n = 5; ∗P ≤ 0.05 vs. control-diet/saline; #P ≤ 0.05 vs. control-diet/TNBS). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 5 Effect of dietary glycine on a chronic model of TNBS colitis. Experimental design as in Figure 1 except that the severity of colonic damage was evaluated 14 days after a single TNBS administration. Dietary treatment was continued throughout the period. The representative macroscopic photographs of chronic ulceration caused by TNBS in the (A) control-diet group and the (B) glycine-diet group are shown (bars = 1 cm). Representative microphotographs of TNBS-induced chronic ulceration in the colon in the (C) control diet— and (D) glycine diet—fed rats are shown (H&E staining original magnification: 40×). The average levels of (E) macroscopic score and (F) histologic score 14 days after TNBS treatment are plotted (n = 5; ∗P < 0.05 vs. control-diet/saline group; #P < 0.05 vs. control-diet/TNBS group). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 6 Effect of dietary glycine on established TNBS colitis. Dietary treatment with/without glycine was started 48 hours after a single TNBS enema, and the severity of colonic damage was evaluated 5 days later (7 days after TNBS treatment). The representative macroscopic photographs of 8-cm portions of the distal colon in the control- and glycine-diet groups given TNBS are shown (A, bars = 1 cm). Representative microphotographs of TNBS-induced ulceration in the colon in the (B) control diet— and (C) glycine diet—fed rats are shown (H&E staining original magnification: 40×). The average levels of (D) macroscopic score and (E) histologic score are plotted (n = 10; ∗P ≤ 0.05 vs. control-diet/saline group; #P ≤ 0.05 vs. control-diet/TNBS group). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 7 Macroscopic changes of the colon and hematocrit values after DSS administration. Rats were pretreated with control or glycine diet for 3 days, and subsequently they were given 3% DSS orally in drinking water ad libitum for 5 days. (A) The gross appearance of colon was observed 5 days later. Bars indicate 5-cm lengths. The average values of the (B) total colon lengths and (C) hematocrit are plotted (n = 10; ∗P ≤ 0.05 vs. control-diet/water alone group; #P ≤ 0.05 vs. control-diet/DSS group). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)

Figure 8 Histopathologic changes and tissue MPO activities in the colon after DSS treatment. Experimental design as in Figure 7. Representative microphotographs of the colonic tissue from the (A) control-diet group without DSS, (B) the glycine-diet group without DSS, (C) 5 days after DSS treatment with control diet, and (D) glycine diet are shown (H&E staining original magnification: 200×). The (E) average levels of histologic scoring and the (F) average tissue MPO activities in the colon at day 5 of DSS treatment are plotted (n = 10; means ± SEM; ∗P ≤ 0.05 vs. control-diet/water alone; #P ≤ 0.05 vs. control-diet/DSS). Gastroenterology 2003 125, 775-785DOI: (10.1016/S0016-5085(03)01067-9)